Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuesTek Innovations is a global leader in Integrated Computational Materials Engineering (ICME), specializing in the design and deployment of high-performance materials. Using its proprietary ICMD® platform, the company employs a 'Materials by Design' methodology to accelerate the development of novel alloys for the aerospace, energy, and medical industries. In the healthcare sector, QuesTek focuses on creating advanced biocompatible materials for medical devices, such as high-strength orthopedic implants and corrosion-resistant cardiovascular stents. Their computational approach significantly reduces the time and cost associated with traditional trial-and-error material development. The company serves as a strategic partner to major OEMs and government agencies, providing material modeling, digital twin technology, and licensing for its patented alloy solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QuesTek Innovations.